PlainRecalls
FDA Drug Moderate Class II Terminated

AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-530-08.

Reported: October 27, 2021 Initiated: September 22, 2021 #D-0022-2022

Product Description

AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-530-08.

Reason for Recall

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
3,240 inhalers
Distribution
USA Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-530-08.. Recalled by Teva Pharmaceuticals USA. Units affected: 3,240 inhalers.
Why was this product recalled?
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Which agency issued this recall?
This recall was issued by the FDA Drug on October 27, 2021. Severity: Moderate. Recall number: D-0022-2022.